01Core principlesThe concepts and mechanisms needed to understand the subject.
Post-craniotomy infection is a group of anatomical syndromes rather than one diagnosis. Superficial incisional disease involves skin and subcutaneous tissue. Deep incisional infection reaches fascia, muscle, bone flap, fixation material or cranioplasty. Organ-space disease includes epidural or subdural empyema, parenchymal abscess and meningitis or ventriculitis. More than one compartment may be involved, and a CSF leak can connect the wound to deeper spaces.
Timing is variable. Early erythema, tenderness, swelling, drainage or wound separation may be obvious, while indolent bone-flap or cranioplasty infection may present later with recurrent discharge, sinus formation, loosening or pain. Fever may be absent after antibiotics or in immune compromise. A sterile inflammatory reaction, seroma, haematoma, contact dermatitis and tumour-related wound breakdown can mimic infection, so anatomy, trajectory, imaging and deep samples matter.
Neurological symptoms make this an intracranial problem until shown otherwise. New seizure, focal deficit, meningism, severe headache, confusion or declining consciousness after craniotomy should trigger urgent CT for haemorrhage, mass effect and hydrocephalus and contrast MRI with DWI when stable enough to define empyema, abscess, cerebritis and bone or soft-tissue involvement. Do not delay emergency management for perfect imaging in sepsis or pressure crisis.
Sampling strategy follows severity. Blood cultures are appropriate with fever or systemic illness. Pus, tissue, bone and implant-adjacent material obtained at debridement have greater relevance to a deep process than a surface swab; send aerobic and anaerobic culture and add fungal, mycobacterial, molecular and histological tests when the host, timing or appearance warrants. Prior antibiotics lower yield, but severe illness must not wait untreated simply to improve culture positivity.
Source control is compartment-specific. Superficial cellulitis without collection or implant involvement may be treated medically with close surgical follow-up. A collection needs drainage; devitalised tissue and infected bone may need debridement; meningitis/ventriculitis or a CSF device needs its own pathway. The historical default for deep bone-flap infection is removal with delayed cranioplasty. Small retrospective series support selected flap washout/replacement or immediate titanium reconstruction, but gross purulence was associated with higher recurrence when a flap was replaced. The responsible cranial surgeon must decide preservation versus removal.
Empirical antimicrobials depend on superficial versus intracranial depth, time from surgery, implanted material, prior drugs, local resistance, allergy and renal function. NICE NG125 supplies general SSI cellulitis advice, not a neurosurgical implant regimen. IDSA supplies healthcare-associated ventriculitis/meningitis recommendations, not a universal wound protocol. Therefore, use the current named neurosurgical and microbiology pathway, then narrow to deep culture results and set duration by compartment, bone/implant involvement, source control and response.
Prevention and follow-up include clean wound care, avoidance of unnecessary handling, management of CSF leakage and explicit discharge instructions. Routine prophylactic extension, topical agents, dressing schedules and implant handling are protocol-specific and should not be improvised. After treatment, monitor wound healing, inflammatory and neurological trajectory, radiological resolution where indicated and readiness for delayed reconstruction.
Key points
- First define depth: superficial incisional infection involves skin/subcutaneous tissue; deep infection involves fascia, muscle, bone flap or implant; organ-space infection includes epidural/subdural empyema, brain abscess or meningitis/ventriculitis.
- Wound appearance alone cannot define intracranial extension. New headache, seizure, focal deficit, meningism, reduced consciousness or CSF leakage prompts immediate neurosurgical review and contrast CT or MRI with DWI as appropriate.
- Obtain blood cultures in systemic illness and deep operative tissue/fluid cultures before antibiotics when this causes no unsafe delay; a superficial swab can misrepresent colonisation and must not be the sole deep-infection sample.
- NICE supports antibiotics covering likely organisms for suspected surgical-site cellulitis, but deep cranial, bone-flap, implant and organ-space infections require specialist antimicrobial and source-control pathways.
- Traditional management removes an infected bone flap and debrides tissue, but selected flap retention or immediate reconstruction is reported when tissue is viable and gross purulence is absent. Small retrospective evidence does not create a universal preservation rule.
- Do not transfer IDSA CSF-device recommendations to every cranial wound. A shunt/drain infection, meningitis or ventriculitis is a distinct device-associated syndrome with its own removal, sampling and antimicrobial decisions.
02Mechanisms and patternsImportant relationships and how to distinguish them.
Local erythema, warmth, tenderness and limited discharge without deep separation, implant exposure, CSF leak, systemic illness or neurological features may be superficial, but requires surgical review and reassessment.
Dehiscence, persistent sinus, purulence, exposed hardware, bone-flap pain or instability and recurrent drainage suggest deep incisional, bone or biofilm-associated infection.
Severe headache, meningism, seizure, focal deficit, reduced consciousness or imaging evidence of epidural/subdural collection, brain abscess or ventriculitis marks intracranial infection.
Clear or blood-tinged fluid from the wound, nose or ear after cranial surgery can create an infection route; confirm clinically and involve the operating team rather than repeatedly manipulating the wound.
A shunt, drain, cranioplasty or fixation plate introduces biofilm and may require removal, externalisation or staged reconstruction. The rule depends on the exact device and compartment.
Seroma, haematoma, sterile inflammatory reaction, allergy and tumour-related breakdown can resemble SSI. Sampling and imaging should resolve uncertainty without delaying treatment of an unstable patient.
03Interpreting evidenceInformation, measurements and their limitations.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Direct wound and neurological assessment - Why
- Define surface findings, dehiscence, CSF leakage, implant exposure and evidence of intracranial extension.
- Interpretation and limitations
- Document wound edges, tenderness, warmth, drainage character, fluctuance and neurological baseline. Do not probe or manipulate a possible deep tract outside the surgical plan.
- 02
Contrast CT and MRI brain with DWI - Why
- Detect superficial/deep collection, bone or implant involvement, empyema, abscess, ventriculitis, oedema and other postoperative causes of decline.
- Interpretation and limitations
- CT is rapid for mass effect, haemorrhage, bone and gas; MRI better defines soft tissue, diffusion-restricting pus and intracranial extension. Early postoperative enhancement is not automatically infection.
- 03
Deep operative cultures and histology - Why
- Identify the pathogen and distinguish infection from sterile inflammation or tumour.
- Interpretation and limitations
- Sample pus, viable/deep tissue, bone and implant-adjacent material before antibiotics when safely possible. Surface swab alone may reflect colonisation and cannot define deep microbiology.
- 04
Blood cultures - Why
- Identify bacteraemia in fever, rigors, sepsis or suspected haematogenous contribution.
- Interpretation and limitations
- Obtain before antimicrobials if this does not delay rescue. Persistent positive cultures require source and metastatic-focus assessment.
- 05
Inflammatory and safety blood tests - Why
- Assess systemic response and antimicrobial/operative fitness.
- Interpretation and limitations
- CRP, full blood count, renal and liver function support trending but can be normal or nonspecific. No marker excludes a localised implant infection.
- 06
CSF sampling only through the authorised pathway - Why
- Diagnose suspected meningitis or ventriculitis when a safe, clinically indicated route exists.
- Interpretation and limitations
- Do not perform lumbar puncture with mass effect or an obstructed pressure gradient and do not sample a drain routinely. Neurosurgery/infection teams choose the route and interpret cell count, chemistry and culture after surgery or antibiotics.
04Applied reasoningWorked examples connecting principles to decisions.
01Worked case: deep infectionPurulent dehiscence with new seizureTwo weeks after craniotomy, a patient has wound separation and purulent drainage, fever and a new focal seizure.+
- 1Treat this as deep or organ-space infection: stabilise, treat the seizure, document neurology and call the operating neurosurgeon plus infection/microbiology teams immediately.
- 2Take blood cultures if this causes no delay and obtain urgent CT, followed by contrast MRI with DWI when appropriate, to define collections and intracranial complications.
- 3Start the current local post-neurosurgical empirical regimen after cultures, or immediately if unstable, and prepare operative exploration, debridement and deep sampling.
- 4At surgery, define skin, galea, bone flap, fixation/implant and organ-space involvement; decide removal, retention or staged reconstruction from viability, purulence and the full source-control context.
- 5Narrow therapy to deep culture results and monitor wound, neurology and imaging; manage CSF leak, meningitis/ventriculitis or abscess through their distinct pathways.
02Depth pathwayClassify before choosing treatment intensityA postoperative cranial wound has erythema, swelling or drainage.+
- 1Assess whether findings remain superficial or include dehiscence, collection, bone, implant, CSF leak, systemic illness or neurological change.
- 2Use imaging and deep sampling when depth is uncertain or any deep/organ-space feature exists; do not base the diagnosis on a surface swab.
- 3Use general SSI cellulitis guidance only for genuinely superficial disease and activate neurosurgical source control for deeper compartments.
03Implant pathwayDecide preservation versus removalDeep infection involves a bone flap, plate or cranioplasty.+
- 1Assess gross purulence, tissue and flap viability, osteomyelitis, organism, soft-tissue cover, prior failure and intracranial extension.
- 2Recognise that preservation or immediate reconstruction evidence is retrospective and selected; gross purulence argues against assuming safe flap replacement.
- 3Document the multidisciplinary source-control and reconstruction plan, culture-directed therapy and surveillance for recurrence.
05Checking understandingVerify the reasoning, revisit uncertainties and apply feedback.
- Inspect and document the wound without unnecessary manipulation; trend dehiscence, drainage, swelling, pain and CSF leakage.
- Repeat GCS components, pupils, focal neurology and seizure assessment when deep or intracranial infection is possible.
- Trend temperature, haemodynamics, cultures and CRP while recognising that markers do not replace wound, neurological and imaging assessment.
- Monitor antimicrobial renal, hepatic, haematological and interaction toxicity for the actual regimen selected by specialists.
- After debridement or implant management, follow healing and recurrence and plan delayed cranioplasty or reconstruction only after specialist confirmation of infection control.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Depth determines the pathway
Skin cellulitis, bone-flap infection and intracranial empyema may share redness or fever but need different imaging, sampling, source control and treatment.
A swab is not the flap
Surface growth can reflect colonisation. Deep tissue, bone and collection samples are needed to direct treatment of deep infection.
Purulence changes preservation
Selected series support flap retention or immediate reconstruction, but gross purulence increases concern for recurrence and weakens a preservation strategy.
Enhancement has a postoperative context
Expected healing can enhance. Diffusion, collection morphology, serial change, symptoms and operative findings determine infection probability.
Device syndromes remain separate
A cranial wound, bone flap, cranioplasty and CSF shunt/drain are not interchangeable implant infections; each has different source-control rules.
07Common pitfallsFrequent interpretation and management errors.
- 01
Calling every red wound superficial cellulitis without assessing implant and organ-space extension.
- 02
Using a superficial swab as the sole microbiology for deep or bone-flap infection.
- 03
Treating a postoperative neurological decline as infection alone without urgent imaging for haemorrhage, infarction, seizure and hydrocephalus.
- 04
Assuming every infected flap must be retained or every infected flap must be removed regardless of purulence and tissue viability.
- 05
Applying a CSF-device antibiotic or removal rule to all cranial implants.
- 06
Prescribing one regimen or duration without current local resistance, compartment, cultures, source control and renal context.